Cargando…

Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh

BACKGROUND: Vitamin D improves absorption of calcium; however, in animal studies vitamin D also increases the absorption of toxic metals, such as lead and cadmium. OBJECTIVES: We examined maternal and neonatal cord blood levels of lead, cadmium, manganese, and mercury after supplementation with vita...

Descripción completa

Detalles Bibliográficos
Autores principales: Jukic, Anne Marie Z., Zuchniak, Anna, Qamar, Huma, Ahmed, Tahmeed, Mahmud, Abdullah Al, Roth, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682582/
https://www.ncbi.nlm.nih.gov/pubmed/33226277
http://dx.doi.org/10.1289/EHP7265
_version_ 1783612711985217536
author Jukic, Anne Marie Z.
Zuchniak, Anna
Qamar, Huma
Ahmed, Tahmeed
Mahmud, Abdullah Al
Roth, Daniel E.
author_facet Jukic, Anne Marie Z.
Zuchniak, Anna
Qamar, Huma
Ahmed, Tahmeed
Mahmud, Abdullah Al
Roth, Daniel E.
author_sort Jukic, Anne Marie Z.
collection PubMed
description BACKGROUND: Vitamin D improves absorption of calcium; however, in animal studies vitamin D also increases the absorption of toxic metals, such as lead and cadmium. OBJECTIVES: We examined maternal and neonatal cord blood levels of lead, cadmium, manganese, and mercury after supplementation with vitamin D during pregnancy. METHODS: The Maternal Vitamin D for Infant Growth trial was a randomized, placebo-controlled, multi-arm study of maternal vitamin D supplementation during pregnancy in Dhaka, Bangladesh (NCT01924013). Women were randomized during their second trimester to blinded weekly doses of placebo or 4,200, 16,800, or 28,000 IU of vitamin D3 throughout pregnancy. Each group had 118–239 maternal blood specimens and 100–201 cord blood samples analyzed. Metals were measured using inductively coupled plasma mass spectrometry. Unadjusted estimates from linear regression models were expressed as percentage differences. Cord blood cadmium was analyzed as detectable or undetectable with log-binomial regression. RESULTS: Maternal cadmium, mercury, and manganese levels were nearly identical across groups. Maternal lead levels were 6.3%, 7.4%, and 6.0% higher in the treatment groups (4,200, 16,800, and 28,000 IU, respectively) vs. placebo; however, 95% confidence intervals (CIs) showed that differences from 4.1% lower to 20% higher were compatible with the data. In treatment groups (4,200, 16,800, 28,000 IU) vs. placebo, neonatal cord blood lead levels were 8.5% (95% CI: [Formula: see text] , 22), 16% (95% CI: 3.3, 30), and 11% (95% CI: 0.4, 23) higher and had higher risk of detectable cadmium, relative risk [Formula: see text] (95% CI: 1.3, 3.7), [Formula: see text] (95% CI: 0.8, 2.5), [Formula: see text] (95% CI: 1.0, 2.9). DISCUSSION: Vitamin D supplementation from the second trimester of pregnancy did not influence maternal cadmium, mercury, or manganese levels at delivery. Vitamin D was associated with nonsignificant increases in maternal lead and with significant increases in cord blood lead and cadmium. These associations were not dose dependent. Given that there are no safe levels of metals in infants, the observed increases in cord blood lead and cadmium require further exploration. https://doi.org/10.1289/EHP7265
format Online
Article
Text
id pubmed-7682582
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-76825822020-11-24 Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh Jukic, Anne Marie Z. Zuchniak, Anna Qamar, Huma Ahmed, Tahmeed Mahmud, Abdullah Al Roth, Daniel E. Environ Health Perspect Research BACKGROUND: Vitamin D improves absorption of calcium; however, in animal studies vitamin D also increases the absorption of toxic metals, such as lead and cadmium. OBJECTIVES: We examined maternal and neonatal cord blood levels of lead, cadmium, manganese, and mercury after supplementation with vitamin D during pregnancy. METHODS: The Maternal Vitamin D for Infant Growth trial was a randomized, placebo-controlled, multi-arm study of maternal vitamin D supplementation during pregnancy in Dhaka, Bangladesh (NCT01924013). Women were randomized during their second trimester to blinded weekly doses of placebo or 4,200, 16,800, or 28,000 IU of vitamin D3 throughout pregnancy. Each group had 118–239 maternal blood specimens and 100–201 cord blood samples analyzed. Metals were measured using inductively coupled plasma mass spectrometry. Unadjusted estimates from linear regression models were expressed as percentage differences. Cord blood cadmium was analyzed as detectable or undetectable with log-binomial regression. RESULTS: Maternal cadmium, mercury, and manganese levels were nearly identical across groups. Maternal lead levels were 6.3%, 7.4%, and 6.0% higher in the treatment groups (4,200, 16,800, and 28,000 IU, respectively) vs. placebo; however, 95% confidence intervals (CIs) showed that differences from 4.1% lower to 20% higher were compatible with the data. In treatment groups (4,200, 16,800, 28,000 IU) vs. placebo, neonatal cord blood lead levels were 8.5% (95% CI: [Formula: see text] , 22), 16% (95% CI: 3.3, 30), and 11% (95% CI: 0.4, 23) higher and had higher risk of detectable cadmium, relative risk [Formula: see text] (95% CI: 1.3, 3.7), [Formula: see text] (95% CI: 0.8, 2.5), [Formula: see text] (95% CI: 1.0, 2.9). DISCUSSION: Vitamin D supplementation from the second trimester of pregnancy did not influence maternal cadmium, mercury, or manganese levels at delivery. Vitamin D was associated with nonsignificant increases in maternal lead and with significant increases in cord blood lead and cadmium. These associations were not dose dependent. Given that there are no safe levels of metals in infants, the observed increases in cord blood lead and cadmium require further exploration. https://doi.org/10.1289/EHP7265 Environmental Health Perspectives 2020-11-23 /pmc/articles/PMC7682582/ /pubmed/33226277 http://dx.doi.org/10.1289/EHP7265 Text en https://ehp.niehs.nih.gov/about-ehp/license EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Research
Jukic, Anne Marie Z.
Zuchniak, Anna
Qamar, Huma
Ahmed, Tahmeed
Mahmud, Abdullah Al
Roth, Daniel E.
Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title_full Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title_fullStr Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title_full_unstemmed Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title_short Vitamin D Treatment during Pregnancy and Maternal and Neonatal Cord Blood Metal Concentrations at Delivery: Results of a Randomized Controlled Trial in Bangladesh
title_sort vitamin d treatment during pregnancy and maternal and neonatal cord blood metal concentrations at delivery: results of a randomized controlled trial in bangladesh
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682582/
https://www.ncbi.nlm.nih.gov/pubmed/33226277
http://dx.doi.org/10.1289/EHP7265
work_keys_str_mv AT jukicannemariez vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh
AT zuchniakanna vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh
AT qamarhuma vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh
AT ahmedtahmeed vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh
AT mahmudabdullahal vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh
AT rothdaniele vitamindtreatmentduringpregnancyandmaternalandneonatalcordbloodmetalconcentrationsatdeliveryresultsofarandomizedcontrolledtrialinbangladesh